MED - רווח תפעולי לפני פחת medifastinc.com

סמל מסחרי של Medifast (MED)

Medifast, Inc. (MED) combines in-house production with external IT outsourcing. Leadership in the wellness niche is driven by unique OPTAVIA coaching. The baseline EBITDA demonstrates a balance between supply and demand, while 0.00 determines the latest valuation metric. However, the expansion of new weight-loss drugs poses serious threats to revenue and the stability of the mentor network.

רווח תפעולי EBITDA: Medifast Inc. (MED) עבור 23.11.2025 - 11.11.2026

פילוחי נתונים אנליטיים מרוכזים עבור Medifast (MED)

- שווי שוק ותחזית יעד של אנליסטים:
הערכת שווי פונדמנטלית של החברה:Medifast, Inc MED
מוצר מקורי של OPTAVIA

This indicator tracks daily cash flow from core operations before depreciation and interest, allowing investors to monitor real-time operational efficiency. Analyzing absolute EBITDA helps assess the success of Medifast, Inc. (MED) in optimizing costs and adapting weight loss programs to compete with GLP-1 drugs, revealing the true resilience of the business model prior to the release of quarterly reports.